{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T06:33:03Z","timestamp":1788849183259,"version":"build-2803163510"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2017R1A2A2A05069493"],"award-info":[{"award-number":["NRF-2017R1A2A2A05069493"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2016M3C7A1905074"],"award-info":[{"award-number":["NRF-2016M3C7A1905074"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2016M3C7A1913894"],"award-info":[{"award-number":["NRF-2016M3C7A1913894"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.bbi.2019.03.001","type":"journal-article","created":{"date-parts":[[2019,3,7]],"date-time":"2019-03-07T13:16:10Z","timestamp":1551964570000},"page":"146-162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"special_numbering":"C","title":["Gintonin, a ginseng-derived ingredient, as a novel therapeutic strategy for Huntington\u2019s disease: Activation of the Nrf2 pathway through lysophosphatidic acid receptors"],"prefix":"10.1016","volume":"80","author":[{"given":"Minhee","family":"Jang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Hee","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeeun","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Joong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Yeol","family":"Nah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ik-Hyun","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2019.03.001_b0005","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.freeradbiomed.2013.04.017","article-title":"Role of oxidative DNA damage in mitochondrial dysfunction and Huntington's disease pathogenesis","volume":"62","author":"Ayala-Pena","year":"2013","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.bbi.2019.03.001_b0010","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/pmic.200900195","article-title":"Lysophosphatidic acid receptor activation affects the C13NJ microglia cell line proteome leading to alterations in glycolysis, motility, and cytoskeletal architecture","volume":"10","author":"Bernhart","year":"2010","journal-title":"Proteomics"},{"key":"10.1016\/j.bbi.2019.03.001_b0015","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1042\/BST0351127","article-title":"Chronic microglial activation and progressive dopaminergic neurotoxicity","volume":"35","author":"Block","year":"2007","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bbi.2019.03.001_b0020","doi-asserted-by":"crossref","unstructured":"Brouillet, E., 2014. The 3-NP Model of Striatal Neurodegeneration. Current protocols in neuroscience\/editorial board, Jacqueline N. Crawley ... [et al 67, 9 48 41\u201349 48 14].","DOI":"10.1002\/0471142301.ns0948s67"},{"key":"10.1016\/j.bbi.2019.03.001_b0030","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/j.1601-183X.2012.00840.x","article-title":"LPA5 receptor plays a role in pain sensitivity, emotional exploration and reversal learning","volume":"11","author":"Callaerts-Vegh","year":"2012","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.bbi.2019.03.001_b0035","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1093\/brain\/awn230","article-title":"Role of microglial IKKbeta in kainic acid-induced hippocampal neuronal cell death","volume":"131","author":"Cho","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.bbi.2019.03.001_b0040","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3389\/fphar.2018.00515","article-title":"Multi-target protective effects of gintonin in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-mediated model of Parkinson's disease via lysophosphatidic acid receptors","volume":"9","author":"Choi","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbi.2019.03.001_b0045","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3389\/fphar.2015.00245","article-title":"Ginseng pharmacology: a new paradigm based on gintonin-lysophosphatidic acid receptor interactions","volume":"6","author":"Choi","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbi.2019.03.001_b0050","doi-asserted-by":"crossref","first-page":"13384","DOI":"10.1073\/pnas.97.24.13384","article-title":"Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior","volume":"97","author":"Contos","year":"2000","journal-title":"PNAS"},{"key":"10.1016\/j.bbi.2019.03.001_b0055","first-page":"43","article-title":"The Keap1-Nrf2 cell defense pathway\u2013a promising therapeutic target? Advances in pharmacology (San Diego","volume":"63","author":"Copple","year":"2012","journal-title":"Calif"},{"key":"10.1016\/j.bbi.2019.03.001_b0060","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.bbadis.2009.07.012","article-title":"Mitochondria in Huntington's disease","volume":"1802","author":"Damiano","year":"2010","journal-title":"Biochim. Biophys. ActaProteins Proteomics"},{"key":"10.1016\/j.bbi.2019.03.001_b0065","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1006\/exnr.2002.7933","article-title":"Mice overexpressing 70-kDa heat shock protein show increased resistance to malonate and 3-nitropropionic acid","volume":"176","author":"Dedeoglu","year":"2002","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbi.2019.03.001_b0070","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1586\/14737175.2016.1134322","article-title":"Defining the therapeutic time window for suppressing the inflammatory prostaglandin E2 signaling after status epilepticus","volume":"16","author":"Du","year":"2016","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.bbi.2019.03.001_b0075","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0306-4522(02)00205-1","article-title":"Subacute systemic 3-nitropropionic acid intoxication induces a distinct motor disorder in adult C57Bl\/6 mice: behavioural and histopathological characterisation","volume":"114","author":"Fernagut","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbi.2019.03.001_b0080","doi-asserted-by":"crossref","first-page":"657","DOI":"10.2147\/NDT.S6430","article-title":"Tetrabenazine: the first approved drug for the treatment of chorea in US patients with Huntington disease","volume":"6","author":"Frank","year":"2010","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.bbi.2019.03.001_b0090","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.3109\/10715762.2014.936432","article-title":"Do glial cells play an anti-oxidative role in Huntington's disease?","volume":"48","author":"Gao","year":"2014","journal-title":"Free Radical Res."},{"key":"10.1016\/j.bbi.2019.03.001_b0095","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1242\/dev.104901","article-title":"An essential role for LPA signalling in telencephalon development","volume":"141","author":"Geach","year":"2014","journal-title":"Development"},{"key":"10.1016\/j.bbi.2019.03.001_b0100","doi-asserted-by":"crossref","first-page":"454","DOI":"10.2174\/1389450115666140115113734","article-title":"The role of oxidative stress in Huntington's disease: are antioxidants good therapeutic candidates?","volume":"15","author":"Gil-Mohapel","year":"2014","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.bbi.2019.03.001_b0105","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00441-010-0977-5","article-title":"LPA receptor expression in the central nervous system in health and following injury","volume":"341","author":"Goldshmit","year":"2010","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.bbi.2019.03.001_b0110","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1517\/14728222.7.2.187","article-title":"MAPKs: new targets for neurodegeneration","volume":"7","author":"Harper","year":"2003","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.bbi.2019.03.001_b0115","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3892\/ijo.2012.1709","article-title":"Suppression of metastasis of intravenously-inoculated B16\/F10 melanoma cells by the novel ginseng-derived ingredient, gintonin: involvement of autotaxin inhibition","volume":"42","author":"Hwang","year":"2013","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbi.2019.03.001_b0120","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3233\/JAD-2012-120439","article-title":"Gintonin, a ginseng-derived lysophosphatidic acid receptor ligand, attenuates Alzheimer's disease-related neuropathies: involvement of non-amyloidogenic processing","volume":"31","author":"Hwang","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbi.2019.03.001_b0125","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/aps.2013.100","article-title":"Yin and Yang of ginseng pharmacology: ginsenosides vs gintonin","volume":"34","author":"Im","year":"2013","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bbi.2019.03.001_b0130","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1007\/s12035-015-9230-2","article-title":"Sulforaphane ameliorates 3-nitropropionic acid-induced striatal toxicity by activating the Keap1-Nrf2-ARE pathway and inhibiting the MAPKs and NF-kappaB pathways","volume":"53","author":"Jang","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbi.2019.03.001_b0135","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.bbi.2014.01.015","article-title":"Ethyl pyruvate ameliorates 3-nitropropionic acid-induced striatal toxicity through anti-neuronal cell death and anti-inflammatory mechanisms","volume":"38","author":"Jang","year":"2014","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2019.03.001_b0140","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/237207","article-title":"Korean red ginseng extract attenuates 3-nitropropionic acid-induced huntington's-like symptoms","volume":"2013","author":"Jang","year":"2013","journal-title":"Evidence Based Complement Altern. Med."},{"key":"10.1016\/j.bbi.2019.03.001_b0145","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3389\/fncel.2018.00157","article-title":"Adeno-associated viral vector serotype DJ-mediated overexpression of N171\u201382Q-mutant huntingtin in the striatum of juvenile mice is a new model for Huntington\u2019s disease","volume":"12","author":"Jang","year":"2018","journal-title":"Front Cell Neurosci."},{"key":"10.1016\/j.bbi.2019.03.001_b0150","doi-asserted-by":"crossref","first-page":"218","DOI":"10.2174\/157488912803252023","article-title":"The Nrf2-ARE pathway: a valuable therapeutic target for the treatment of neurodegenerative diseases","volume":"7","author":"Joshi","year":"2012","journal-title":"Recent Pat CNS Drug Discov."},{"key":"10.1016\/j.bbi.2019.03.001_b0155","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s00018-007-6484-5","article-title":"Molecular basis for chemoprevention by sulforaphane: a comprehensive review","volume":"64","author":"Juge","year":"2007","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbi.2019.03.001_b0160","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s004410050061","article-title":"Neuronal death after brain injury. Models, mechanisms, and therapeutic strategies in vivo","volume":"298","author":"Kermer","year":"1999","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.bbi.2019.03.001_b0165","doi-asserted-by":"crossref","first-page":"7999","DOI":"10.1523\/JNEUROSCI.2675-04.2004","article-title":"Activation of the IkappaB kinase complex and nuclear factor-kappaB contributes to mutant huntingtin neurotoxicity","volume":"24","author":"Khoshnan","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2019.03.001_b0170","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jgr.2015.05.001","article-title":"Hippocampus-dependent cognitive enhancement induced by systemic gintonin administration","volume":"40","author":"Kim","year":"2016","journal-title":"J. Ginseng Res."},{"issue":"36","key":"10.1016\/j.bbi.2019.03.001_b9000","doi-asserted-by":"crossref","first-page":"24308","DOI":"10.1074\/jbc.M803341200","article-title":"Transforming growth factor-beta requires its target plasminogen activator inhibitor-1 for cytostatic activity","volume":"283","author":"Kortlever","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbi.2019.03.001_b0175","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.freeradbiomed.2014.04.014","article-title":"Inducible nitric oxide synthase is key to peroxynitrite-mediated, LPS-induced protein radical formation in murine microglial BV2 cells","volume":"73","author":"Kumar","year":"2014","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.bbi.2019.03.001_b0180","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1476-5381.2011.01418.x","article-title":"Role of LOX\/COX pathways in 3-nitropropionic acid-induced Huntington's disease-like symptoms in rats: protective effect of licofelone","volume":"164","author":"Kumar","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbi.2019.03.001_b0185","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature11556","article-title":"A call for transparent reporting to optimize the predictive value of preclinical research","volume":"490","author":"Landis","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.bbi.2019.03.001_b0190","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.neulet.2015.12.026","article-title":"Gintonin enhances performance of mice in rotarod test: involvement of lysophosphatidic acid receptors and catecholamine release","volume":"612","author":"Lee","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbi.2019.03.001_b0195","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13024-016-0116-1","article-title":"IKKbeta-mediated inflammatory myeloid cell activation exacerbates experimental autoimmune encephalomyelitis by potentiating Th1\/Th17 cell activation and compromising blood brain barrier","volume":"11","author":"Lee","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bbi.2019.03.001_b0200","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s12035-014-9012-2","article-title":"Bee venom acupuncture alleviates experimental autoimmune encephalomyelitis by upregulating regulatory T cells and suppressing Th1 and Th17 responses","volume":"53","author":"Lee","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbi.2019.03.001_b0205","doi-asserted-by":"crossref","first-page":"17608","DOI":"10.1074\/jbc.M111.330183","article-title":"Targeted deletion of LPA5 identifies novel roles for lysophosphatidic acid signaling in development of neuropathic pain","volume":"287","author":"Lin","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbi.2019.03.001_b0210","doi-asserted-by":"crossref","first-page":"19035","DOI":"10.1074\/jbc.C000180200","article-title":"Activation of MLK2-mediated signaling cascades by polyglutamine-expanded huntingtin","volume":"275","author":"Liu","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbi.2019.03.001_b0220","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.plipres.2015.01.004","article-title":"Lysophosphatidic acid receptor (LPAR) modulators: the current pharmacological toolbox","volume":"58","author":"Llona-Minguez","year":"2015","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.bbi.2019.03.001_b0225","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/nn1988","article-title":"Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease","volume":"10","author":"Lobsiger","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbi.2019.03.001_b0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018192","article-title":"LPA5 is abundantly expressed by human mast cells and important for lysophosphatidic acid induced MIP-1beta release","volume":"6","author":"Lundequist","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bbi.2019.03.001_b0235","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1744-8069-9-29","article-title":"An LPA species (18:1 LPA) plays key roles in the self-amplification of spinal LPA production in the peripheral neuropathic pain model","volume":"9","author":"Ma","year":"2013","journal-title":"Mol. Pain"},{"key":"10.1016\/j.bbi.2019.03.001_b0240","doi-asserted-by":"crossref","first-page":"25946","DOI":"10.1074\/jbc.M102691200","article-title":"Expression and function of lysophosphatidic acid receptors in cultured rodent microglial cells","volume":"276","author":"Moller","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbi.2019.03.001_b0245","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/glia.22543","article-title":"SDF-1alpha and LPA modulate microglia potassium channels through rho gtpases to regulate cell morphology","volume":"61","author":"Muessel","year":"2013","journal-title":"Glia"},{"key":"10.1016\/j.bbi.2019.03.001_b0250","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.2174\/138945012803529947","article-title":"Gintonin: a novel ginseng-derived ligand that targets G protein- coupled lysophosphatidic acid receptors","volume":"13","author":"Nah","year":"2012","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.bbi.2019.03.001_b0255","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1002\/dvdy.21736","article-title":"Expression patterns of the lysophospholipid receptor genes during mouse early development","volume":"237","author":"Ohuchi","year":"2008","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.bbi.2019.03.001_b0260","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1523\/JNEUROSCI.17-09-03064.1997","article-title":"Mechanisms of cell death induced by the mitochondrial toxin 3-nitropropionic acid: acute excitotoxic necrosis and delayed apoptosis","volume":"17","author":"Pang","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2019.03.001_b0265","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1212\/01.wnl.0000222734.56412.17","article-title":"Microglial activation correlates with severity in Huntington disease: a clinical and PET study","volume":"66","author":"Pavese","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.bbi.2019.03.001_b0270","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/624132","article-title":"A novel Korean red ginseng compound gintonin inhibited inflammation by MAPK and NF-kappaB pathways and recovered the levels of mir-34a and mir-93 in RAW 264.7 Cells","volume":"2015","author":"Saba","year":"2015","journal-title":"Evidence Based Complement Altern. Med."},{"issue":"3","key":"10.1016\/j.bbi.2019.03.001_b9005","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/8.3.397","article-title":"Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin","volume":"8","author":"Schilling","year":"1999","journal-title":"Hum. Mol. Genet."},{"issue":"15","key":"10.1016\/j.bbi.2019.03.001_b9010","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1093\/hmg\/ddh175","article-title":"Nuclear-targeting of mutant huntingtin fragments produces Huntington's disease-like phenotypes in transgenic mice","volume":"13","author":"Schilling","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbi.2019.03.001_b0275","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1111\/j.1460-9568.2004.03265.x","article-title":"Functional importance of Ca2+-activated K+ channels for lysophosphatidic acid-induced microglial migration","volume":"19","author":"Schilling","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bbi.2019.03.001_b0280","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0006-8993(96)01387-X","article-title":"Fluoro-Jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration","volume":"751","author":"Schmued","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.bbi.2019.03.001_b0285","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.freeradbiomed.2010.03.017","article-title":"Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington's disease","volume":"49","author":"Stack","year":"2010","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.bbi.2019.03.001_b0290","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0304-3940(99)00906-4","article-title":"Activation of mitogen-activated protein kinases in gerbil hippocampus with ischemic tolerance induced by 3-nitropropionic acid","volume":"278","author":"Sugino","year":"2000","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbi.2019.03.001_b0295","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.tips.2013.04.005","article-title":"Toward clinical application of the Keap1-Nrf2 pathway","volume":"34","author":"Suzuki","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbi.2019.03.001_b0300","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/415078","article-title":"Sulforaphane as a potential protective phytochemical against neurodegenerative diseases","volume":"2013","author":"Tarozzi","year":"2013","journal-title":"Oxid Med. Cell Longev."},{"key":"10.1016\/j.bbi.2019.03.001_b0305","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ijdevneu.2003.09.003","article-title":"Microglial activation state and lysophospholipid acid receptor expression","volume":"21","author":"Tham","year":"2003","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.bbi.2019.03.001_b0310","doi-asserted-by":"crossref","first-page":"878","DOI":"10.3390\/molecules15020878","article-title":"3-Nitropropionic acid as a tool to study the mechanisms involved in Huntington's disease: past, present and future","volume":"15","author":"Tunez","year":"2010","journal-title":"Molecules"},{"key":"10.1016\/j.bbi.2019.03.001_b0315","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1471-2199-9-84","article-title":"Mutant huntingtin activates Nrf2-responsive genes and impairs dopamine synthesis in a PC12 model of Huntington's disease","volume":"9","author":"van Roon-Mom","year":"2008","journal-title":"BMC Mol. Biol."},{"key":"10.1016\/j.bbi.2019.03.001_b0320","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1096\/fj.14-262659","article-title":"Lysophosphatidate signaling stabilizes Nrf2 and increases the expression of genes involved in drug resistance and oxidative stress responses: implications for cancer treatment","volume":"29","author":"Venkatraman","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.bbi.2019.03.001_b0325","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3233\/JHD-150149","article-title":"Mass spectrometry analysis of wild-type and knock-in Q140\/Q140 Huntington's disease mouse brains reveals changes in glycerophospholipids including alterations in phosphatidic acid and lyso-phosphatidic acid","volume":"4","author":"Vodicka","year":"2015","journal-title":"J. Huntington's Dis."},{"key":"10.1016\/j.bbi.2019.03.001_b0330","doi-asserted-by":"crossref","first-page":"12490","DOI":"10.1523\/JNEUROSCI.2238-14.2014","article-title":"Substance P exacerbates dopaminergic neurodegeneration through neurokinin-1 receptor-independent activation of microglial NADPH oxidase","volume":"34","author":"Wang","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2019.03.001_b0335","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1002\/mds.26007","article-title":"Targets for future clinical trials in Huntington's disease: what's in the pipeline?","volume":"29","author":"Wild","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbi.2019.03.001_b0340","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/B978-0-12-416618-9.00013-3","article-title":"Methods to monitor ROS production by fluorescence microscopy and fluorometry","volume":"542","author":"Wojtala","year":"2014","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.bbi.2019.03.001_b0345","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.1167\/iovs.06-0871","article-title":"Role of NF-kappaB and MAPKs in light-induced photoreceptor apoptosis","volume":"48","author":"Yang","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.bbi.2019.03.001_b0350","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.neuron.2015.01.009","article-title":"Lysophosphatidic Acid signaling in the nervous system","volume":"85","author":"Yung","year":"2015","journal-title":"Neuron"}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159118303921?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159118303921?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:55:39Z","timestamp":1760169339000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159118303921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":70,"alternative-id":["S0889159118303921"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2019.03.001","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gintonin, a ginseng-derived ingredient, as a novel therapeutic strategy for Huntington\u2019s disease: Activation of the Nrf2 pathway through lysophosphatidic acid receptors","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2019.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}